Researchers have developed a new nuclear medicine imaging method that works by targeting cancer-associated fibroblasts (CAFs), sharing their findings in the Journal of Nuclear Medicine. The authors developed a PET tracer based on a FAP-specific enzyme inhibitor, which outperformed fluorodeoxyglucose and produced high-contrast images in animals and three actual patients.  {read more here}